Skip to main content

Publications

Our 50 latest publications

[1]

J. Garousi et al., "Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours," European journal of pharmaceutics and biopharmaceutics, vol. 134, pp. 37-48, 2019.

[2]

M. Lundqvist et al., "Chromophore pre-maturation for improved speed and sensitivity of split-GFP monitoring of protein secretion," Scientific Reports, vol. 9, 2019.

[3]

P. E. Khoonsari et al., "Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers," Journal of Alzheimer's Disease, vol. 67, no. 2, pp. 639-651, 2019.

[4]

S. Nybond et al., "Adenoviral detection by recombinase polymerase amplification and vertical flow paper microarray.," Analytical and Bioanalytical Chemistry, vol. 411, no. 4, pp. 813-822, 2019.

[5]

A. Kazemzadeh et al., "A micro-dispenser for long-term storage and controlled release of liquids," Nature Communications, vol. 10, no. 1, 2019.

[6]

S. Meister, N. Hendrikse and J. Löfblom, "Directed evolution of the 3C protease from coxsackievirus using a novel fluorescence-assisted intracellular method," Biological chemistry (Print), vol. 400, no. 3, pp. 405-415, 2019.

[7]

L. Nilebäck, "Expanded knowledge on silk assembly for development of bioactive silk coatings," Doctoral thesis : KTH Royal Institute of Technology, TRITA-CBH-FOU, 2019:9, 2019.

[8]

A. Ibrahim et al., "Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity," International Journal of Cancer, vol. 144, no. 12, pp. 3086-3098, 2019.

[9]

S. Deyev et al., "Comparative Evaluation of Two DARPin Variants : Effect of Affinity, Size, and Label on Tumor Targeting Properties," Molecular Pharmaceutics, vol. 16, no. 3, pp. 995-1008, 2019.

[10]

S. Hober, S. Lindbo and J. Nilvebrant, "Bispecific applications of non-immunoglobulin scaffold binders," Methods, vol. 154, pp. 143-152, 2019.

[11]

R. Benfeitas et al., "Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis," EBioMedicine, 2019.

[12]

M. Neiman et al., "Individual and stable autoantibody repertoires in healthy individuals," Autoimmunity, vol. 52, no. 1, pp. 1-11, 2019.

[13]

A. Boutajangout et al., "Affibody-Mediated Sequestration of Amyloid beta Demonstrates Preventive Efficacy in a Transgenic Alzheimer's Disease Mouse Model," Frontiers in Aging Neuroscience, vol. 11, 2019.

[14]

K. G. Andersson et al., "Autotransporter-Mediated Display of a Naive Affibody Library on the Outer Membrane of Escherichia coli," Biotechnology Journal, vol. 14, no. 4, 2019.

[15]

B. Turanli et al., "Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning," EBioMedicine, vol. 42, pp. 386-396, 2019.

[16]

A. Vorobyeva et al., "Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2," International Journal of Oncology, vol. 54, no. 4, pp. 1209-1220, 2019.

[17]

U. Johansson et al., "Assembly of functionalized silk together with cells to obtain proliferative 3D cultures integrated in a network of ECM-like microfibers.," Scientific Reports, vol. 9, no. 1, 2019.

[18]

S. Papiol et al., "HIGH-THROUGHPUT ANTIBODY-BASED PROFILING OF SERUM IN SCHIZOPHRENIA AND BIPOLAR DISORDER PATIENTS : AN INTEGRATIVE GENOMICS-PROTEOMICS PILOT STUDY," European Neuropsychopharmacology, vol. 29, pp. S993-S994, 2019.

[19]

A. Häggmark et al., "A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection," Molecular & Cellular Proteomics, vol. 18, no. 3, pp. 461-476, 2019.

[20]

M. Pernemalm et al., "In-depth human plasma proteome analysis captures tissue proteins and transfer of protein variants across the placenta," eLIFE, vol. 8, 2019.

[21]

H. Idborg et al., "Circulating Levels of Interferon Regulatory Factor-5 Associates With Subgroups of Systemic Lupus Erythematosus Patients," Frontiers in Immunology, vol. 10, 2019.

[22]

M. Ahmed et al., "Human serum albumin-based probes for molecular targeting of macrophage scavenger receptors," International Journal of Nanomedicine, vol. 14, pp. 3723-3741, 2019.

[23]

A. Andersson et al., "Development of parallel reaction monitoring assays for cerebrospinal fluid proteins associated with Alzheimer's disease," Clinica Chimica Acta, vol. 494, pp. 79-93, 2019.

[24]

M. Mikus et al., "Asthma Sub-Phenotyping in Plasma from U-BIOPRED and BIOAIR Using Array-Based Proteomics," American Journal of Respiratory and Critical Care Medicine, vol. 199, 2019.

[25]

S. Yu et al., "An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation," PLoS ONE, vol. 14, no. 5, 2019.

[26]

C. P. Halvorsen et al., "A rapid smartphone-based lactate dehydrogenase test for neonatal diagnostics at the point of care," Scientific Reports, vol. 9, 2019.

[27]

L. Nilebäck et al., "Bioactive Silk Coatings Reduce the Adhesion of Staphylococcus aureus while Supporting Growth of Osteoblast-like Cells," ACS Applied Materials and Interfaces, vol. 11, no. 28, pp. 24999-25007, 2019.

[28]

S. Yu, "Exploitation of interactions with the neonatal Fc receptor to manipulate biological half-lives for therapeutic applications," Doctoral thesis Stockholm : KTH Royal Institute of Technology, TRITA-CBH-FOU, 2019:41, 2019.

[29]

P. Reu et al., "A 61% lighter cell culture dish to reduce plastic waste," PLoS ONE, vol. 14, no. 4, 2019.

[30]

B. Katona et al., "Antibody Validation Strategy for Nuclear Receptors.," Methods in Molecular Biology, vol. 1966, pp. 79-99, 2019.

[31]

J. Wang et al., "A miR-206 regulated gene landscape enhances mammary epithelial differentiation.," Journal of Cellular Physiology, vol. 234, no. 12, pp. 22220-22233, 2019.

[32]

S. Björk, "Droplet microfluidics for screening and sorting of microbial cell factories," Doctoral thesis : KTH Royal Institute of Technology, TRITA-CBH-FOU, 2019:43, 2019.

[33]

D. Söderberg et al., "Bioactive composites of cellulose nanofibrils and recombinant silk proteins," Abstracts of Papers of the American Chemical Society, vol. 257, 2019.

[34]

J.-M. Perotin et al., "Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux," European Respiratory Journal, vol. 53, no. 6, 2019.

[35]

R. W. Koivula, J. M. Schwenk and P. W. Franks, "Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes : descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium," Diabetologia, vol. 62, no. 9, pp. 1601-1615, 2019.

[36]

H. Ding et al., "Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody-DM1 Drug Conjugates," Cancers, vol. 11, no. 8, 2019.

[37]

E. Karlöf et al., "Correlation of computed tomography with carotid plaque transcriptomes associates calcification with lesion-stabilization," Atherosclerosis, vol. 288, pp. 175-185, 2019.

[38]

I. Das et al., "Elucidate the underlying molecular mechanisms of the combination treatment effects of Afatinib (EGFR/HER2 inhibitor) and Crizotinib (MET inhibitor) in cutaneous malignant melanoma (CMM)," Journal of Investigative Dermatology, vol. 139, no. 9, pp. S298-S298, 2019.

[39]

A. Stamm et al., "A retrobiosynthesis-based route to generate pinene-derived polyesters," ChemBioChem (Print), vol. 20, pp. 1664-1671, 2019.

[40]

C. E. Thomas et al., "Individual effects of gastric bypass surgery on longitudinal blood protein profiles : an IMI DIRECT study," Diabetologia, vol. 62, pp. S271-S271, 2019.

[41]

H. R. Wilman et al., "Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration," Journal of Hepatology, vol. 71, no. 3, pp. 594-602, 2019.

[42]

E. Lundberg, "Dissecting the spatiotemporal subcellular distribution of the human proteome," European Journal of Human Genetics, vol. 27, pp. 764-764, 2019.

[43]

F. Mesmar et al., "Clinical candidate and genistein analogue AXP107-11 has chemoenhancing functions in pancreatic adenocarcinoma through G protein-coupled estrogen receptor signaling," Cancer Medicine, 2019.

[44]

C. Pineau et al., "Cell Type-Specific Expression of Testis Elevated Genes Based on Transcriptomics and Antibody-Based Proteomics," Journal of Proteome Research, 2019.

[45]

A.-L. Lind et al., "CSF levels of apolipoprotein C1 and autotaxin found to associate with neuropathic pain and fibromyalgia," Journal of Pain Research, vol. 12, pp. 2875-2889, 2019.

[46]

P. Dusart et al., "A Systems-Based Map of Human Brain Cell-Type Enriched Genes and Malignancy-Associated Endothelial Changes," Cell reports, vol. 29, no. 6, pp. 1690-+, 2019.

[47]

A. Vorobyeva et al., "Imaging of EpCAM expression in pancreatic cancer using radiolabelled DARPin Ec1," European Journal of Nuclear Medicine and Molecular Imaging, vol. 46, no. SUPPL 1, pp. S749-S750, 2019.

[48]

J. Garousi et al., "Comparison Of Affibody- And Antibody Fragments-based Caix Imaging Probes In Mice Bearing Renal Cell Carcinoma Xenografts," European Journal of Nuclear Medicine and Molecular Imaging, vol. 46, no. SUPPL 1, pp. S80-S80, 2019.

[49]

V. Tolmachev et al., "First-in-humans Evaluation of [Tc-99m]-ADAPT6, a Novel Scaffold Protein for Visualizationof HER2 Expression," European Journal of Nuclear Medicine and Molecular Imaging, vol. 46, no. SUPPL 1, pp. S166-S166, 2019.

[50]

M. Altai et al., "Evaluation Of Several Newly Designed Affibody-based Drug Conjugates Using Radionuclide-based Techniques : A Powerful Tool For Drug Development," European Journal of Nuclear Medicine and Molecular Imaging, vol. 46, no. SUPPL 1, pp. S715-S716, 2019.